Publication:
OnabotulinumtoxinA (Botox (R)) and AbobotulinumtoxinA (Dysport (R)) in Treating Essential Blepharospasm: Long Term Results

Simple item page
dc.contributor.authorNUHOĞLU, FADİME
dc.contributor.authorOzdemir, Fatma Esin
dc.contributor.authorKarademir, Zeliha
dc.contributor.authorEltutar, Kadir
dc.contributor.institutionauthorNUHOĞLU, FADİME
dc.date.accessioned2020-10-22T16:01:31Z
dc.date.available2020-10-22T16:01:31Z
dc.date.issued2016-08-01T00:00:00Z
dc.description.abstractObjective: To compare the clinical characteristics and outcomes of patients with blepharospasm who were treated with OnabotulinumtoxinA (Botox (R)) and AbobotulinumtoxinA (Dysport (R)).
dc.identifier.citationNUHOĞLU F., Ozdemir F. E. , Karademir Z., Eltutar K., -OnabotulinumtoxinA (Botox (R)) and AbobotulinumtoxinA (Dysport (R)) in Treating Essential Blepharospasm: Long Term Results-, JOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREM, cilt.6, ss.110-114, 2016
dc.identifier.doi10.5152/jarem.2016.1061
dc.identifier.urihttp://hdl.handle.net/20.500.12645/23865
dc.identifier.wosWOS:000382989100009
dc.titleOnabotulinumtoxinA (Botox (R)) and AbobotulinumtoxinA (Dysport (R)) in Treating Essential Blepharospasm: Long Term Results
dc.typeArticle
dspace.entity.typePublication
local.avesis.id660390f0-9ce6-4b92-bc76-b60eba8a32da
local.indexed.atWOS
local.publication.isinternational1
relation.isAuthorOfPublication451cef24-7964-4542-9283-62e67fa13932
relation.isAuthorOfPublication.latestForDiscovery451cef24-7964-4542-9283-62e67fa13932

Files

Collections

Yayınlar - Eserler